Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2010 Feb 24:10:15.
doi: 10.1186/1471-2377-10-15.

Improving adherence to medication in stroke survivors (IAMSS): a randomised controlled trial: study protocol

Affiliations
Randomized Controlled Trial

Improving adherence to medication in stroke survivors (IAMSS): a randomised controlled trial: study protocol

Ronan O'Carroll et al. BMC Neurol. .

Abstract

Background: Adherence to therapies is a primary determinant of treatment success, yet the World Health Organisation estimate that only 50% of patients who suffer from chronic diseases adhere to treatment recommendations. In a previous project, we found that 30% of stroke patients reported sub-optimal medication adherence, and this was associated with younger age, greater cognitive impairment, lower perceptions of medication benefits and higher specific concerns about medication. We now wish to pilot a brief intervention aimed at (a) helping patients establish a better medication-taking routine, and (b) eliciting and modifying any erroneous beliefs regarding their medication and their stroke.

Methods/design: Thirty patients will be allocated to a brief intervention (2 sessions) and 30 to treatment as usual. The primary outcome will be adherence measured over 3 months using Medication Event Monitoring System (MEMS) pill containers which electronically record openings. Secondary outcomes will include self reported adherence and blood pressure.

Discussion: This study shall also assess uptake/attrition, feasibility, ease of understanding and acceptability of this complex intervention.

Trial registration: Current Controlled Trials ISRCTN38274953.

PubMed Disclaimer

Figures

Figure 1
Figure 1
CONSORT flowchart of trial design.

References

    1. World Health Organisation. Adherence to long term therapies: evidence for action. Geneva: World Health Organisation; 2003.
    1. Stephenson J. Noncompliance may cause half of antihypertensive drug "failures". Journal of the American Medical Association. 1999;282:313–314. doi: 10.1001/jama.282.4.313. - DOI - PubMed
    1. Newby LK, LaPointe NM, Chen AY, Kramer JM, Hammill BG, DeLong ER, Muhlbaier LH, Califf RM. Long-term adherence to evidence-based secondary prevention therapies in coronary artery disease. Circulation. 2006;113:203–212. doi: 10.1161/CIRCULATIONAHA.105.505636. - DOI - PubMed
    1. Rasmussen JN, Chong A, Alter DA. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. Journal of the American Medical Association. 2007;297:177–186. doi: 10.1001/jama.297.2.177. - DOI - PubMed
    1. Albert NM. Improving medication adherence in chronic cardiovascular disease. Critical Care Nurse. 2008;28:54–64. - PubMed

Publication types

Associated data